↓ Skip to main content

Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption

Overview of attention for article published in New England Journal of Medicine, April 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Readers on

mendeley
26 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
Published in
New England Journal of Medicine, April 2019
DOI 10.1056/nejmoa1802264
Pubmed ID
Authors

Chang-Yi Wang, Wing-Wai Wong, Hung-Chin Tsai, Yen-Hsu Chen, Be-Sheng Kuo, Shugene Lynn, Jana Blazkova, Katherine E. Clarridge, Hsiao-Wen Su, Chia-Ying Lin, Fan-Chen Tseng, Annie Lai, Fu-Hung Yang, Chen-Han Lin, William Tseng, Hsiao-Yi Lin, Connie L. Finstad, Flossie Wong-Staal, Carl V. Hanson, Tae-Wook Chun, Mei-June Liao

Twitter Demographics

The data shown below were collected from the profiles of 79 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 26 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 26 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 19%
Student > Master 4 15%
Student > Bachelor 4 15%
Unspecified 4 15%
Researcher 3 12%
Other 6 23%
Readers by discipline Count As %
Medicine and Dentistry 10 38%
Unspecified 6 23%
Biochemistry, Genetics and Molecular Biology 4 15%
Pharmacology, Toxicology and Pharmaceutical Science 3 12%
Agricultural and Biological Sciences 1 4%
Other 2 8%

Attention Score in Context

This research output has an Altmetric Attention Score of 302. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 May 2019.
All research outputs
#36,761
of 13,055,439 outputs
Outputs from New England Journal of Medicine
#1,229
of 25,209 outputs
Outputs of similar age
#1,157
of 231,885 outputs
Outputs of similar age from New England Journal of Medicine
#48
of 261 outputs
Altmetric has tracked 13,055,439 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 25,209 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 61.7. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 231,885 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 261 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.